Home
Solution
Impact
Science
Publications
About
Team and Board
News and Events
All News
All Events
All Press Releases
Contact
Xinnate – press releas image
Home
News
Xinnate Receives FDA IND Approval for TCP-25, Enabling Pivotal Phase 2/3 STEP Study in Epidermolysis Bullosa
Xinnate – press releas image
